For what appears to be the first time, the FDA scolded a company for a promotional display that falsely claimed its ...

The FDA has sent its first untitled letter of 2025, hitting Edenbridge Pharmaceuticals with a notice after assessin | The FDA ...

Big Pharma won. Last November, the FDA issued requirements that ads give consumers a “non-misleading net impression about the advertised drug.” The agency stated that information had to be ...

The U.S. Food and Drug Administration ... false or misleading prescription drug promotions. Meanwhile it also provides consumers, doctors and competitors a way to report advertising that may ...

False or misleading claims made in drug advertisements may harm persons who rely on those claims. Direct-to-consumer advertising of prescription drugs may result in inappropriate prescribing of ...

Lawmakers are urging the FDA to address misleading advertisements by Hims & Hers, a telehealth company promoting injectable weight-loss drugs without adequate safety and risk disclosures.

Drug industry bodies and politicians labelled the advert misleading while pharmacy compounding ... bagging on the weight loss industry and then advertising a weight loss pill?” ...

The Partnership for Safe Medicines, a group consisting of more than 40 community and pharmacy groups, asked the Food and Drug Administration to "take action" and "protect Americans from misleading ...